Effect of formulation parameters and drug-polymer interactions on drug release from starch acetate matrix tablets

Journal of Pharmaceutical Sciences

Volumn 98, Issue 10, 2009, Pages 3676-3690

  Pajander, Jari ^a   Korhonen, Ossi ^a   Laamanen, Maria ^a   Ryynänen, Eeva Leena ^a   Grimsey, Ian ^b   Van Veen, Bert ^c   Ketolainen, Jarkko ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

^c ORION CORPORATION   (Finland)

Author keywords

Drug release; Hydrophobic polymer; Interaction; Matrix tablet; QSPR

Indexed keywords

ACICLOVIR; ALLOPURINOL; METRONIDAZOLE; PARACETAMOL; POLYMER; SALICYLAMIDE; STARCH ACETATE; THEOPHYLLINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; HYDROPHILICITY; HYDROPHOBICITY; PARTICLE SIZE; TABLET POROSITY;

EID: 70349255620     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21689     Document Type: Article

References (29)

1. Mäki R, Suihko E, Korhonen O, Pitkänen H, Niemi R, Lehtonen M, Ketolainen J. 2006. Controlled release of saccharides from matrix tablets. Eur J Pharm Biopharm 62:163-170. (Pubitemid 43143268)
2. Steendam R, Eissens ACE, Frijlink HW, Lerk CF. 2000. Plasticisation of amylodextrin by moisture consequences for drug release from tablets. Int J Pharm 204:23-33. (Pubitemid 30782320)
3. Noyes AA, Whitney W. 1897. Auflösungsgeschwindigkeit von festen Stoffen in ihren eigenen Lösungen. Z Phys Chem 23:689.
4. Higuchi T. 1963. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 52:1145-1149.
5. Tatavarti AS, Mehta K, Augsburger LL, Hoag SW. 2004. Influence of methacrylic and acrylic acid polymers on the release performance of weakly basic drugs from sustained release hydrophilic matrices. J Pharm Sci 93:2319-2331. (Pubitemid 39129629)
6. Frank A, Rath SK, Venkatraman SS. 2004. Controlled release from bioerodible polymers: Effect of drug type and polymer composition. J Control Release 102:333-344. (Pubitemid 40093757)
7. Puttipipatkhachorn S, Nuthanid J, Yamamoto K, Peck GE. 2001. Drug physical state and drug-polymer interaction on drug release from chitosan matrix films. J Control Release 75:143-153. (Pubitemid 32635204)
8. Miyajima M, Koshika A, Okada J, Ikeda M. 1999. Effect of polymer/basic drug interactions on the two-stage diffusion-controlled release from a poly(L-lactic acid) matrix. J Control Release 61:295-304. (Pubitemid 29413024)
9. Hsiue GH, Liao CM, Lin SY. 1998. Effect of drug-polymer interaction on the release characteristics of methacrylic acid copolymer microcapsules containing theophylline. Artif Organs 22:651-656.
10. Coughlan DC, Corrigan OI. 2006. Drug-polymer interactions and their effect on thermoresponsive poly(N-isopropylacrylamide) drug delivery systems. Int J Pharm 313:163-174.
11. Jenquin MR, McGinity JW. 1994. Characterization of acrylic resin matrix films and mechanisms of drug-polymer interactions. Int J Pharm 101:24-34.
12. Pohja S, Suihko E, Vidgren M, Paronen P, Ketolainen J. 2004. Starch acetate as a tablet matrix for sustained drug release. J Control Release 94:293-302. (Pubitemid 38117141)
13. Korhonen O, Raatikainen P, Harjunen P, Nakari J, Suihko E, Vidgren M, Paronen P. 2000. Starch acetates - Multifunctional direct compression excipients. Pharm Res 17:1138-1143. (Pubitemid 30822400)
14. Korhonen O, Pohja S, Peltonen S, Suihko E, Vidgren M, Paronen P, Ketolainen J. 2002. Effects of physical properties for starch acetate powders on tableting. AAPS Pharm Sci Tech 3:1-9. (Pubitemid 41086121)
15. van Veen B, Pajander J, Zuurman K, Lappalainen R, Poso A, Frijlink HW, Ketolainen J. 2005. The effect of powder blend and tablet structure on drug release mechanisms of hydrophobic starch acetate matrix tablets. Eur J Pharm Biopharm 61:149-157. (Pubitemid 41427623)
16. Pajander J, van Veen B, Korhonen O, Lappalainen R, Ketolainen J. 2006. Liquid boundary movements in cylindrical and convex hydrophobic matrix tablets: Effects on tablet cracking and drug release. Eur J Pharm Biopharm 64:167-172. (Pubitemid 44291997)
17. Pajander J, Soikkeli AM, Korhonen O, Forbes RT, Ketolainen J. 2008. Drug release phenomena within a hydrophobic starch acetate matrix: FTIR mapping of tablets after in vitro dissolution testing. J Pharm Sci 97:3367-3378.
18. Huuskonen J, Livinstone DJ, Manallack DT. 2008. Prediction of drug solubility from molecular structure using a drug-like training set. SAR QSAR Environ Res 19:191-212. (Pubitemid 351998854)
19. Jouyban A, Soltanpour S, Soltani S, Chan HK, Acree WE. 2007. Solubility prediction of drugs in water-cosolvent mixtures using Abraham solvation parameters. J Pharm Pharm Sci 10:263-277. (Pubitemid 47073984)
20. Gafourian T, Safari A, Adibkia K, Parviz F, Nokhodchi A. 2007. A drug release study from hydroxypropylmethylcellulose (HPMC) matrices using QSPR modeling. J Pharm Sci 96:3334-3351.
21. Korhonen O, Matero S, Poso A, Ketolainen J. 2005. Partial least square projections to latent structures analysis (PLS) in evaluating and predicting drug release from starch acetate matrix tablets. J Pharm Sci 94:2716-2730. (Pubitemid 43265394)
22. Moffat AC, Osselton MD, Widdop B, editors. 2006. Clarke's analysis of drugs and poisons. London, UK: Pharmaceutical Press.
23. Chang RK, Shinwari M, Leonzio M, Wu LS, Pang J, Hussain MA. 1998. Evaluation of the disintegrant properties for an experimental crosslinked polyalkylammonium polymer. Int J Pharm 179:87-92. (Pubitemid 29027763)
24. Zeng XM, Martin GP, Marriott C. 2001. Factors affecting particulate interactions. In: Zeng XM, Martin GP, Marriott C, editors. Particulate interactions in dry powder formulations for inhalation. London: Taylor & Francis. pp 12-25.
25. Sutton HM. 1976. Flow properties of powders and the role of surface character. In: Parfitt GD, Sing KSW, editors. Characterization of powder surfaces with special reference to pigments and fillers. London: Academic press. pp 107-158.
26. Barra J, Lescure F, Falson-Rieg F, Doelker E. 1998. Can the organization of a binary mix be predicted from the surface energy, cohesion parameter and particle size of its components? Pharm Res 15:1727-1736.
27. Mäki R, Suihko E, Rost S, Heiskanen M, Murtomaa M, Lehto VP, Ketolainen J. 2006. Modifying drug release and tablet properties of starch acetate tablets by dry powder agglomeration. J Pharm Sci 96:438-447.
28. Rupp F, Scheideler L, Olshanska N, de Wild M, Wieland M, Geis-Gerstrofer J. 2005. Enhancing surface free energy and hydrophilicity through chemical modification of microstructured titanium implant surfaces. J Biomed Mater Res A 76:323-334.
29. York P, Ticehurst MD, Osborn JC, Roberts RJ, Rowe RC. 1998. Characterisation of the surface energetics of milled dl-propranolol hydrochloride using inverse gas chromatography and molecular modelling. Int J Pharm Sci 174:179-186. (Pubitemid 28487002)